Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Susanne Schinke

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
Deutsche Medizinische Wochenschrift (1946)|April 15, 2016
[Systemic sclerosis]Susanne Schinke, Gabriela Riemekasten
Der Internist|November 23, 2019
[Systemic sclerosis]Susanne Schinke, Gabriela Riemekasten
Pediatric Pulmonology|January 20, 2004
BPI-ANCA of pediatric cystic fibrosis patients can impair BPI-mediated killing of E. coli DH5alpha in vitroHendrik Schultz, Susanne Schinke, Katharina Mosler, et al.
Rheumatology Advances in Practice|October 8, 2021
The treatment of Merkel cell carcinoma with immune checkpoint inhibitors: implications for patients with rheumatoid arthritisGina Klee, Tobias Kisch, Christiane Kümpers, et al.
Seminars in Arthritis and Rheumatism|February 29, 2008
Refractory central nervous system vasculitis and gastrocnemius myalgia syndrome in Crohn's disease successfully treated with anti-tumor necrosis factor-alpha antibodySebastian Ullrich, Susanne Schinke, Markus Both, et al.
Arthritis Research & Therapy|February 22, 2014
Plasma cells within granulomatous inflammation display signs pointing to autoreactivity and destruction in granulomatosis with polyangiitisAntje Mueller, Christoph Brieske, Susanne Schinke, et al.
Inflammatory Bowel Diseases|January 1, 2005
Autoantibodies against the bactericidal/permeability-increasing protein from inflammatory bowel disease patients can impair the antibiotic activity of bactericidal/permeability-increasing proteinSusanne Schinke, Klaus Fellermann, Karen Herlyn, et al.
RMD Open|June 11, 2025
Combination therapy of rituximab and mycophenolate in patients with systemic sclerosis and primary cardiac involvement refractory to cyclophosphamide: a retrospective exploratory analysis of 10 casesEl-Baraa Adjailia, Hanna Grasshoff, Susanne Schinke, et al.
Respiratory Medicine|October 2, 2024
Metabolomic signature identifies HDL and apolipoproteins as potential biomarker for systemic sclerosis with interstitial lung diseaseSebastian T Jendrek, Franziska Schmelter, Susanne Schinke, et al.
Annals of the Rheumatic Diseases|June 1, 2010
Prospective long-term follow-up of patients with localised Wegener's granulomatosis: does it occur as persistent disease stage?Julia U Holle, Wolfgang L Gross, Konstanze Holl-Ulrich, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Deutsche Medizinische Wochenschrift (1946)|April 15, 2016
[Systemic sclerosis]Susanne Schinke, Gabriela Riemekasten
Der Internist|November 23, 2019
[Systemic sclerosis]Susanne Schinke, Gabriela Riemekasten
Pediatric Pulmonology|January 20, 2004
BPI-ANCA of pediatric cystic fibrosis patients can impair BPI-mediated killing of E. coli DH5alpha in vitroHendrik Schultz, Susanne Schinke, Katharina Mosler, et al.
Rheumatology Advances in Practice|October 8, 2021
The treatment of Merkel cell carcinoma with immune checkpoint inhibitors: implications for patients with rheumatoid arthritisGina Klee, Tobias Kisch, Christiane Kümpers, et al.
Seminars in Arthritis and Rheumatism|February 29, 2008
Refractory central nervous system vasculitis and gastrocnemius myalgia syndrome in Crohn's disease successfully treated with anti-tumor necrosis factor-alpha antibodySebastian Ullrich, Susanne Schinke, Markus Both, et al.
Arthritis Research & Therapy|February 22, 2014
Plasma cells within granulomatous inflammation display signs pointing to autoreactivity and destruction in granulomatosis with polyangiitisAntje Mueller, Christoph Brieske, Susanne Schinke, et al.
Inflammatory Bowel Diseases|January 1, 2005
Autoantibodies against the bactericidal/permeability-increasing protein from inflammatory bowel disease patients can impair the antibiotic activity of bactericidal/permeability-increasing proteinSusanne Schinke, Klaus Fellermann, Karen Herlyn, et al.
RMD Open|June 11, 2025
Combination therapy of rituximab and mycophenolate in patients with systemic sclerosis and primary cardiac involvement refractory to cyclophosphamide: a retrospective exploratory analysis of 10 casesEl-Baraa Adjailia, Hanna Grasshoff, Susanne Schinke, et al.
Respiratory Medicine|October 2, 2024
Metabolomic signature identifies HDL and apolipoproteins as potential biomarker for systemic sclerosis with interstitial lung diseaseSebastian T Jendrek, Franziska Schmelter, Susanne Schinke, et al.
Annals of the Rheumatic Diseases|June 1, 2010
Prospective long-term follow-up of patients with localised Wegener's granulomatosis: does it occur as persistent disease stage?Julia U Holle, Wolfgang L Gross, Konstanze Holl-Ulrich, et al.
Pageof 2